期刊文献+

吉非替尼合成工艺改进 被引量:2

Optimization of the Synthesis for Gefitinib
下载PDF
导出
摘要 目的改进和优化吉非替尼的合成工艺,便于工业化生产。方法以3,4-二甲氧基苯甲醛为原料,先硝化,后依次脱甲基、侧链烷基化、醛基转化为氰基、氰基氧化成酰胺、还原、闭环、氯代最后与3-氯-4-氟苯胺反应合成了抗肿瘤药物吉非替尼。结果总收率约23.6%,产物经核磁共振氢谱、质谱、元素分析确证其结构为目标产物。结论该工艺在分离纯化过程中不需过柱,原料价格便宜,条件温和,操作简单,适合于工业化生产。 Objective To optimize the synthesis method of Gefitinib,in order to provide an industrialized process.Methods Gefitinib was synthesized from 3,4-Dimethoxybenzaldehyde via nitration,demethylation and condensation with N-(3-chloropropyl)morpholine.Conversion of aldehyde to nitrile followed by amidation,reduction,and then cyclization which was finally subjected to be chlorinated and condensed with 3-chloro-4-fluoroaniline.Results Its structure was identified by 1HNMR、MS and EA.The total yield was 23.6%.Conclusion The synthetic method is acceptable for manufacturing with inexpensive materials,mild reaction conditions,simple operation and purification without chromatography.
作者 王莉
出处 《今日药学》 CAS 2011年第12期741-744,共4页 Pharmacy Today
关键词 吉非替尼 表皮生长因子受体 合成 Gefitinib epidermal growth factor receptor(EGFR) synthesis
  • 相关文献

参考文献11

  • 1刁圆圆,张庆文.吉非替尼的合成[J].中国医药工业杂志,2008,39(6):401-403. 被引量:14
  • 2金波,陈国华,邹爱峰,石涛,任金山.吉非替尼的合成[J].中国药科大学学报,2005,36(1):92-94. 被引量:11
  • 3黄世杰.AstraZeneca公司的gefitinib有希望复合治疗非小细胞肺癌[J].国外医学(药学分册),2003,30(2):118-118. 被引量:4
  • 4朱崇泉,迟玉石,邓银来,郭峰,黄文龙,曹庆先.4-(3-氯-4-氟苯基胺基)-7-甲氧基-6-(3-吗啉丙氧基)喹唑啉的制备方法[P]中国专利:CN1733738. 被引量:1
  • 5Gibson KH.Preparation of haloanilinoquinazolines as ClassⅠreceptor tyrosine kinase inhibitors. WO 9633980 . 1996 被引量:1
  • 6Sandeep K,Illen J.Hexaalkoxytricycloquinazolines:Newdiscotic liquid crystals. Journal of Organic Chemistry . 1993 被引量:1
  • 7Frampton J E,Easthope S E.Gefitinib. Drugs . 2004 被引量:1
  • 8Rro Dharmaraj Ramachandra.Process for the preparation of Gefitinib. WO2008125867 . 2008 被引量:1
  • 9Gilday JP,Moody D.Process for the preparation of4-(3-chloro-4--uoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline. WO,2004024703 . 2004 被引量:1
  • 10Rogers B C,Blum Charles A M,Bryam P.Improved syntheses of6-hydroxy-5-methoxy-and5-hydroxy-6-methoxyindoles and their O-acetates,analogs of nnatural eumelanin precursors. Journal of Heterocyclic Chemistry . 1987 被引量:1

二级参考文献11

  • 1张艳华,宁华,姜洋.表皮生长因子受体酪氨酸激酶抑制剂吉非替尼[J].中国新药杂志,2004,13(10):947-950. 被引量:13
  • 2AstraZeneca plc(GB) oncolytic EGF receptor tyrosine kinase inhibitor IressaTM [J].Drugs of the Future,2002,27(4):339-345. 被引量:1
  • 3Kieth HG. Quinazoline derivatives.US 5770599. 被引量:1
  • 4Alexander J. Bridges, Hairong Zhou, et al. Tyrosie kinase inhibitors.8.an unusually steep structure-activity relationship for analogues of 4-(3-bromoanilino)-6,7-dimethoxyquinazoline (PD153035),a potent inhibitor of the epidermal growth factor receptor [J]. J Med Chem,1996,39(1):267-276. 被引量:1
  • 5Frampton JE, Easthope SE. Gefitinib [J]. Drugs, 2004, 64 (21) : 2475-2492. 被引量:1
  • 6Gibson KH. Preparation of haloanilinoquinazolines as Class I receptor tyrosine kinase inhibitors: WO, 9633980 [P]. 1996-10-31. (CA 1997, 126: 47235) 被引量:1
  • 7Gilday JP, Moody D. Process for the preparation of 4- (3-chloro-4-fluoroanilino) -7-methoxy-6- (3-morpholinopropoxy) quinazoline: WO, 2004024703 [P]. 2004-03-25. (CA 2004, 140: 287403). 被引量:1
  • 8Ramanadham JP, Muddasani PR, Bollepalli NR, et al. An improved process for the preparation of gefitinib: WO, 2005070909 [P]. 2005-08-04. (CA2005, 143: 194029). 被引量:1
  • 9Katrizky AR, Pilarski B, Urogdi L. Efficient conversion of nitriles to amides with basic hydrogen peroxide in dimethyl sulfoxide [J]. Synthesis, 1989, (12): 949-950. 被引量:1
  • 10Adams RR, Whitmore FC. Heterocyclic basic compounds. IV 2-Aminoalkylamino-pyrimidines [J]. JAm Chem Soc, 1945 67(5) : 735-738. 被引量:1

共引文献18

同被引文献8

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部